Scienture Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
SCNX$3.20+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED BALANCE SHEETS
December 31, 2025 and 2024
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $6,662,008 | $308,096 |
| Accounts receivable, net | 731,328 | 11,106 |
| Inventory | 213,408 | - |
| Prepaid expenses | 262,278 | 4,560 |
| Notes receivable - related party | - | 1,300,000 |
| Other receivables | - | 4,138,770 |
| Deferred offering costs | 47,384 | 534,800 |
| Current assets of discontinued operations | - | 8,145 |
| Total current assets | 7,916,406 | 6,305,477 |
| Property, plant and equipment, net | 15,500 | 17,500 |
| Deposits | - | 22,039 |
| Notes receivable | 5,000,000 | - |
| Interest receivable | 250,000 | - |
| Intangible assets, net | 70,973,064 | 76,400,000 |
| Goodwill | - | 21,372,960 |
| Operating lease right-of-use assets | 23,360 | 201,433 |
| Deferred tax asset | - | 534,396 |
| Total assets | $84,178,330 | $104,853,805 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities: | ||
| Accounts payable | $1,443,266 | $2,898,683 |
| Accrued liabilities | 657,034 | 1,313,731 |
| Other current liabilities | - | 5,441 |
| Loan payable, related party | - | 415,000 |
| Convertible note, net of debt discount - current portion | - | 2,285,423 |
| Operating lease liability - current | 24,137 | 63,334 |
| Warrant liability | 10,914 | 919,935 |
| Development agreement liability - current portion | 600,000 | - |
| Current liabilities of discontinued operations | - | 5,346 |
| Total current liabilities | 2,735,351 | 7,906,893 |
| Convertible notes, net of debt discount | - | 612,275 |
| Derivative liability | - | 2,296,834 |
| Operating lease liability - net of current portion | - | 156,469 |
| Development agreement liability | 285,000 | 1,285,000 |
| Deferred tax liability | 11,037,595 | 13,524,213 |
| Total liabilities | 14,057,946 | 25,781,684 |
| Commitments and contingencies (Note 15) | - | - |
| Stockholders’ equity (deficit): | ||
| Series A preferred stock, $0.00001 par value; 0 and 9,211,246 shares authorized; 0 shares issued and outstanding as of both December 31, 2025 and 2024 | - | - |
| Series B preferred stock, $0.00001 par value; 787,754 shares authorized; 15,759 shares issued and outstanding as of both December 31, 2025 and 2024 | - | - |
| Series C preferred stock, $0.00001 par value; 1,000 shares authorized; 0 shares issued and outstanding as of both December 31, 2025 and 2024 | - | - |
| Series X preferred stock, $0.00001 par value; 9,211,246 shares authorized; 0 shares issued and outstanding as of both December 31, 2025 and 2024 | - | - |
| Common stock, $0.00001 par value; 100,000,000 shares authorized; 40,630,815 and 8,750,582 shares issued and outstanding as of December 31, 2025 and 2024, respectively 1,015,000 and 0 shares unvested as of December 31, 2025 and 2024, respectively | 406 | 87 |
| Additional paid-in capital | 150,671,215 | 118,111,007 |
| Accumulated deficit | (80,551,237) | (39,038,973) |
| Total stockholders’ equity | 70,120,384 | 79,072,121 |
| Total liabilities and stockholders’ equity | $84,178,330 | $104,853,805 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.